HR4492-119

Introduced

To amend title 11, United States Code, to account for the protection of genetic information in bankruptcy.

119th Congress Introduced Jul 17, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill creates protection of genetic information in bankruptcy proceedings. It relies on requirement, disclosure, and data standard. The main policy areas are Finance, Bankruptcy Law, Healthcare, and Technology.

Who Benefits and How

Consumers who provided genetic data to testing companies would be affected and Data security and sanitization service providers could gain revenue opportunities.

Who Bears the Burden and How

Genetic testing companies (23andMe, Ancestry.com, etc.) would be affected, Bankruptcy trustees and debtors in possession would be affected, and Potential acquirers of genetic testing company assets would be affected.

Key Provisions

  • Creates protection of genetic information in bankruptcy proceedings.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill creates protection of genetic information in bankruptcy proceedings.

Key Policy Areas

Finance, Bankruptcy Law, Healthcare, Technology

Primary Purpose

The bill creates protection of genetic information in bankruptcy proceedings.

Policy Domains

Finance Bankruptcy Law Healthcare Technology

Whole bill

Identified Gains
  • Consumers who provided genetic data to testing companies
  • Data security and sanitization service providers
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Data security and sanitization service providers:
Consumers who provided genetic data to testing companies:
Identified Costs
  • Genetic testing companies (23andMe, Ancestry.com, etc.)
  • Bankruptcy trustees and debtors in possession
  • Potential acquirers of genetic testing company assets
  • Creditors of genetic testing companies
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Creditors of genetic testing companies:
Bankruptcy trustees and debtors in possession:
Potential acquirers of genetic testing company assets:
Genetic testing companies (23andMe, Ancestry.com, etc.):

Legislative Progress

Introduced
Introduced Committee Passed
Jul 17, 2025

Mr. Cline (for himself and Ms. Lofgren) introduced the following …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Financial Services
2 mentions across 1 clause
-2 negative

Creditors of genetic testing companies, Potential acquirers of genetic testing company assets

Pharmaceuticals
1 mention across 1 clause
-1 negative

Genetic testing companies (23andMe, Ancestry.com, etc.)

Professional Services
1 mention across 1 clause
-1 negative

Bankruptcy trustees and debtors in possession

Technology
1 mention across 1 clause
+1 positive

Data security and sanitization service providers

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Finance Bankruptcy Law Healthcare Technology

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology